Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 6—June 2019
Perspective

West Nile and Usutu Virus Infections and Challenges to Blood Safety in the European Union

Dragoslav DomanovićComments to Author , Celine M. Gossner, Ryanne Lieshout-Krikke, Wolfgang Mayr, Klara Baroti-Toth, Alina Mirella Dobrota, Maria Antonia Escoval, Olaf Henseler, Christof Jungbauer, Giancarlo Liumbruno, Salvador Oyonarte, Constantina Politis, Imad Sandid, Miljana Stojić Vidović, Johanna J. Young, Inês Ushiro-Lumb, and Norbert Nowotny
Author affiliations: European Centre for Disease Prevention and Control, Solna, Sweden (D. Domanović, C.M. Gossner, J.J. Young); European Blood Alliance, Amsterdam, the Netherlands (R. Lieshout-Krikke); Austrian Red Cross, Vienna, Austria (W. Mayr, C. Jungbauer); National Competent Authority for Blood, Budapest, Hungary (K. Baroti-Toth); National Competent Authority for Blood, Bucharest, Romania [external expert] (A.M. Dobrota); National Competent Authority for Blood, Lisbon, Portugal (M.A. Escoval); Paul Ehrlich Institute, Langen, Germany (O. Henseler); Italian National Blood Centre, National Institute of Health, Rome, Italy (G. Liumbruno); National Competent Authority for Blood, Madrid, Spain (S. Oyonarte); Hellenic Center for Disease Control and Prevention (KEELPNO), Athens, Greece (C. Politis); National Competent Authority for Blood, Paris, France (I. Sandid); Croatian Institute for Transfusion Medicine, Zagreb, Croatia (M.S. Vidović); National Health Service Blood and Transplant (NHSBT), London, UK (I. Ushiro-Lumb); University of Veterinary Medicine, Vienna, Austria (N. Nowotny); Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates (N. Nowotny)

Main Article

Table 2

Autochthonous and imported cases of WNV infection and WNV-positive blood donations by country in the European Union, 2009–2017*

Country and year No. cases of WNV infection, autochthonous (imported) No. WNV-positive blood donations No. blood donations screened WNV-positive blood donations/10,000 donations
Austria†
2014 2 0 67,800 0.00
2015 6 5 74,677 0.67
2016 5 3 70,864 0.42
2017
 6
 2
 67,544
 0.30
France†
2015 1 0 30,900 0.00
2017
 2
 0
 4,044
 0.00
Greece
2010 262 8 27,108 2.95
2011 99 (1) 5 105,610 0.47
2012 160 (2) 4 36,911 1.08
2013 86 1 26,910 0.37
2014 15 0 6,662 0.00
2017
 48
 0
 3,779
 0.00
Italy
2009 18 2 59,815 0.33
2010 11 6 118,295 0.51
2011 32 4 148,255 0.27
2012 73 14 116,255 1.20
2013 126 (3) 19 284,564 0.67
2014 24 4 334,356 0.12
2015 61(1) 16 322,196 0.50
2016 76 (5) 31 455,930 0.68
2017
 57 (1)
 25
 338,900
 0.74
Portugal
2015
 1
 0
 4,247
 0.00
Romania‡
2016 17 1 10,694 0.94
2017
 16
 1
 11,390
 0.88
Spain
2010 2 0 10,768 0.00
2016 3 0 9,457 0.00

*USUV, Usutu virus; WNV, West Nile virus.
†Austria corrected numbers of WNV positive cases and donations by excluding USUV-positive donations in 2016 and 2017. Other affected countries did not make corrections related to possible USUV positivity.
‡Data from affected areas where blood donations were screened.

Main Article

Page created: May 20, 2019
Page updated: May 20, 2019
Page reviewed: May 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external